Larvol Veri

BIOMARKER:

MGMT unmethylation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

MGMT unmethylation MGMT unmethylation	Glioblastoma GBM	temozolomide Sensitive: B - Late Trials temozolomide Sensitive : B
MGMT unmethylation MGMT unmethylation	Glioblastoma GBM	nivolumab + ipilimumab Sensitive: C3 – Early Trials nivolumab + ipilimumab Sensitive : C3
MGMT unmethylation MGMT unmethylation	Glioblastoma GBM	cemiplimab + INO-5401 + INO-9012 Sensitive: C3 – Early Trials cemiplimab + INO-5401 + INO-9012 Sensitive : C3
MGMT unmethylation MGMT unmethylation	Glioblastoma GBM	VAL-083 Sensitive: C3 – Early Trials VAL-083 Sensitive : C3
MGMT unmethylation MGMT unmethylation	Glioblastoma GBM	pembrolizumab Resistant: C3 – Early Trials pembrolizumab Resistant : C3
MGMT unmethylation MGMT unmethylation	Glioblastoma GBM	NOX-A12 Sensitive: C3 – Early Trials NOX-A12 Sensitive : C3